Repros Therapeutics, Inc. (RPRX)

[rstor1]

dewophile,

After the first three-month double blind treatment phase of the study was completed, menstruation commenced a mean of 21 days after treatment was stopped. The bleeding severity as measured by daily diary cards was 28% less than the pretreatment baseline;
After the first four-month open label treatment was completed, menstruation started a mean of 24 days after treatment was stopped. The bleeding severity, as measured by daily diary cards, was 48% less than the pretreatment baseline.

- How reliable is the self-reporting in this setting, especially in an open-label situation.

- Also, does the 48% reduction put the patients with normal range?

TIA,
Bob